Next, we verified the expression of A20/ACSL4 in the tumor by immunohistochemistry, the expression of the ferroptosis marker PTGS2, and the obvious effect of Apatinib + miR-214-3p inhibitors on tumor angiogenesis by CD34. This evidence concerns the gene ACSL4 and neoplasm.